Cite

HARVARD Citation

    Middeke, J. et al. (2021). Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of TP53 mutations – a registry based analysis. Leukemia & lymphoma. 62 (6), pp. 1432-1440. [Online]. 
  
Back to record